Selective NaV1.7 Antagonists With Long Residence Time Show Improved Efficacy Against Inflammatory and Neuropathic Pain
Cell Reports - United States
doi 10.1016/j.celrep.2018.08.063
Full Text
Open PDFAbstract
Available in full text
Date
September 1, 2018
Authors
Publisher
Elsevier BV